Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-16-069710

Options or other derivatives

  • Director acquired 14,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Young Matthew P. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-06-10 Grant or award : show line 1 in the form Stock Option (right to buy) +14,000 14,000 D
Loading xslF345X03/doc1.xml…